Form 8-K - Current report:
SEC Accession No. 0001171843-22-004019
Filing Date
2022-05-31
Accepted
2022-05-31 13:41:45
Documents
12
Period of Report
2022-05-31
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_053122.htm   iXBRL 8-K 27244
  Complete submission text file 0001171843-22-004019.txt   201802

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cmpx-20220531.xsd EX-101.SCH 2992
3 XBRL LABEL FILE cmpx-20220531_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cmpx-20220531_pre.xml EX-101.PRE 22381
6 EXTRACTED XBRL INSTANCE DOCUMENT f8k_053122_htm.xml XML 3722
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39696 | Film No.: 22982254
SIC: 2836 Biological Products, (No Diagnostic Substances)